Document Detail


Stem cells in the management of heart failure: what have we learned from clinical trials?
MedLine Citation:
PMID:  25434419     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Research shows that various types of stem cells (SCs) have the ability to rebuild damaged heart tissue. The TIME and Late TIME human trials shed light on the optimum timing of SC therapy administration after myocardial damage. The FOCUS study failed to show a substantial positive effect of bone marrow-derived mononuclear cells in patients suffering from ischemic heart failure; however, some completed human trials do show promise, with improvement in cardiac function. Recent clinical trials have identified a subset of marrow cells that was able to stimulate endogenous adult cardiac SCs where cardiac SCs administration showed promise in the SCIPIO trial. This review addresses some of the lessons learned from clinical trials with SC therapy in ischemic heart failure.
Authors:
Rebecca Vogel; Emad A Hussein; Shaker A Mousa
Related Documents :
22143079 - Reverse remodeling in heart failure-mechanisms and therapeutic opportunities.
20505799 - The effect of insulin on the heart: part 2: effects on function during and post myocard...
22405659 - Cardiac magnetic resonance imaging for stage b heart failure.
22614699 - Non-obstructive membranes of the left atrial appendage.
25406899 - Adrenergic receptor genotype influences heart failure severity and β-blocker response ...
25441039 - Mechanical circulatory support.
17926199 - Improved assay of cardiac troponin i is more sensitive than other assays of necrosis ma...
2033179 - Left ventricular diastolic filling abnormalities identified by doppler echocardiography...
6748069 - Coronary-prone behavior attitudes in moderate to severe coronary artery occlusion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-29
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  -     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-12-1     Completed Date:  -     Revised Date:  2014-12-2    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Three new polyunsaturated lipids from a Guangxi marine sponge Haliclona sp.
Next Document:  The association between improved quality diabetes indicators, health outcomes and costs: towards con...